Edgewell Personal Care Company Chief Executive Officer Rod R. Little filed a Form 4 on November 12, 2026, reporting the vesting and conversion of restricted stock equivalents and a related share withholding transaction dated November 10, 2026.
Key Highlights
- Vesting event: 14,611 restricted stock equivalents granted on November 10, 2023, vested and converted into shares of Edgewell common stock on November 10, 2026, at a price of $0.
- Shares withheld for taxes: 6,773 shares were withheld at $29.61 per share to satisfy a tax liability upon vesting, per the filing.
- Resulting direct ownership: Following both transactions, Little directly held 382,928 shares of common stock, according to the filing.
- Derivative position reduced to zero: The restricted stock equivalents position associated with the November 10, 2023 grant fell to 0 following the vesting, the filing disclosed.
- Issuer and exchange: Edgewell Personal Care Company trades on NYSE:EPC, as stated on the filing's cover.
Little's RSU Conversion and Tax Withholding at Edgewell Personal Care
According to the Form 4, Rod R. Little, who serves as both a Director and Chief Executive Officer of Edgewell Personal Care Company, reported two non-derivative transactions on November 10, 2026. The first was coded "M," reflecting the vesting and conversion of 14,611 restricted stock equivalents into common stock at a price of $0. This brought his direct beneficial ownership to 389,701 shares at that interim stage, as shown in Table I of the filing.
The second transaction, coded "F," recorded the withholding of 6,773 shares at $29.61 per share. The filing's footnote explains these shares were "withheld as payment of a tax liability on vesting of restricted stock equivalents." After this withholding, Little's directly held position stood at 382,928 shares of Edgewell common stock, as reported in the filing.
Edgewell Personal Care is a consumer goods company whose product portfolio spans personal care categories including razors and blades, feminine care, and sun and skin care brands. The restricted stock equivalents that vested had an original grant date of November 10, 2023, and carried a conversion or exercise price of $0, consistent with a typical equity compensation structure. The filing was signed by Rod R. Little on November 12, 2026.
What Was Disclosed
The filing reported the November 10, 2026 vesting of 14,611 restricted stock equivalents held by Edgewell CEO Rod R. Little, the withholding of 6,773 shares at $29.61 for tax purposes, and a resulting direct ownership of 382,928 shares of common stock.




Please wait processing your request...